Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

EGX:MCRO Financials Overview

Financials in millions EGP. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	894.54	894.54	519.97	526.01	729.61	594.26
Revenue Growth	72.04%	72.04%	-1.15%	-27.91%	22.78%	38.04%
Gross Profit Gross Profit Growth	609.24	609.24	323.12	295.65	561.64	473.87
Operating Income Operating Income Growth	135.45	135.45	12.03	-182.39	234.35	203.62
Net Income Net Income Growth	115.73	115.73	-38.1	-272.65	173.84	147.93
Earnings Per Share EPS Growth	0.20	0.20	-0.07	-0.48	0.30	0.26
EPS Growth	-	-	-	-	17.09%	11.40%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Egypt Egypt Growth	863.75	863.75	485.3	510.98	699.15	587.43
Export Export Growth	30.8	30.8	34.67	15.02	30.46	6.83
Total Total Growth	894.54	894.54	519.97	526.01	729.61	594.26

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	176.04	176.04	62.34	75.31	186.75	60.67
Total Debt Total Debt Growth	333.43	333.43	316.32	226.18	204.65	97.81
Net Cash (Debt) Net Cash Growth	-157.39	-157.39	-253.98	-150.87	-17.89	-37.14
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.28	-0.28	-0.45	-0.27	-0.03	-0.06

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	160.99	160.99	-74.45	-38.01	134.93	50.26
Capital Expenditures CapEx Growth	-42.48	-42.48	-12.32	-6.44	-5.3	-5.81
Free Cash Flow Free Cash Flow Growth	118.51	118.51	-86.76	-44.44	129.63	44.44
Free Cash Flow Growth	-	-	-	-	191.66%	14.31%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	68.11%	68.11%	62.14%	56.21%	76.98%	79.74%
Operating Margin	15.14%	15.14%	2.31%	-34.67%	32.12%	34.26%
Pretax Margin	13.63%	13.63%	-7.61%	-51.34%	31.16%	33.06%
Profit Margin	12.94%	12.94%	-7.33%	-51.83%	23.83%	24.89%
FCF Margin	13.25%	13.25%	-16.69%	-8.45%	17.77%	7.48%

Dividends

Chart

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.107	0.069
Dividend Per Share Growth	54.70%	-
Dividend Yield	15.40%	-

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	7.60	5.62	-	-	10.76	-
Forward PE	21.71	10.07	10.07	10.07	10.07	-
P/FCF Ratio	7.31	5.49	-	-	14.43	-
PS Ratio	0.97	0.73	2.54	3.20	2.56	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error